kidney transplantation Flashcards

1
Q

types of transplant

A
  • deceased heart beatingdonors (brain stem death)
  • nonheart beating donors
  • live donation (altruistic)
    directed and undirected
    paired donation
    financially procured (illegal in most countries)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

assessing potential recipients

A
  • reasonable life expectancy (>5yrs)
  • make sure patient able to undergo anaesthetic, procedure, immunsuppression, post-op
    (takes about 3months until after 3months)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

things assessed:

A
  1. immunology – tissue typing & antibody screening
  2. virology (exclude active infection)
    HBV, HCV, HIV, EBV, CMV, VZV, Toxo, Syphilis
  3. cardioresp risk ECG, Echo +/- ETT, Coronary angio CXR, +/- PFT, CPEX
  4. periph vessels
  5. bladder function
  6. mental state
  7. any co-morbidity/PMHx which may influence transplant or be exacerbated by immunosuppression
  8. independent assessment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

contrainds

A
  • malignancy
    (known untreated malignancy
    solid tumour in last 2-5 years)
  • active infection
  • severe IHD, not amenable to surgery
  • severe airways disease
  • active vasculitis
  • severe PVD (unusable vessels)
  • hostile bladder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

assessing live donors

A
  • physical fitness
  • they fine after 1 kid? isotope GFR
  • normal anatomy kidneys
  • co morbs (hypertension, proteinuria, haematuria)
  • immunological compatible
  • psych compat?
  • no coercion?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

***tissue typing

A

blood group
HLA (major histocompatibility complex MHC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

impmortance of hla mathcing

A

w/o immuno supp - critical!!
if immunosup then better graft survival
sensitisation to subsequent transplants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

sensitising events other than transplantation

A
  • blood transfusion
  • pregnancy or miscarriage
  • previous transplant
  • lead to formation of antibodies to non-self antigens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • ? how to overcome immunological barriers in living donation
A

paired donation or altruistic donation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

desensitisation

A
  • active removal of blood group or donor specific HLA antibody
  • pre-transplant antibody depletion
    plasma exchange
    B cell antibody (rituximab)
  • monitor antibody levels and transplant when below acceptable threshold
  • associated with greater immunosuppression and higher rejection rates.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

transplant procedure itself

A
  • extra peritoneal procedure
  • transplant inserted in iliac fossa
    (attached to external iliac arterty & vein
    ureter plumbed into bladder with stent)
  • wound ~15-20cm long
  • average 2-3 hour operation
  • 7-10 days in hospital
  • regular clinic follow up
  • usually back to full activities & work in 3 months
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

surgical complications of kidney transplant

A
  • bleeding
  • arterial stenosis
  • venous stenosis / kinking
  • ureteric stricture & hydronephrosis or leak
  • wound infection/dehiscence
  • lymphocele
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

signs that tranplant working

A
  1. immediate graft function
    - good urine output
    - falling urea & creatinine
  2. delayed graft function
    - post-transplant ATN
    - often need HD in interim
    - usually works within 10-30days
    - usually need biopsy (difficult to detect rejection)
  3. primary non function
    - transplant never works and is explanted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

types of rejection

A
  1. hyperacute rejection
    - due to preformed antibodies
    - unsalvageable
    - transplant nephrectomy required
  2. acute rejection
    - cellular or antibody mediated
    - can be treated with increased immunosupression
  3. chronic rejection
    - antibody mediated slowly progressive decline in renal function. Poorly responsive to treatment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is anti-rejection therapy and its ideal treatment

A

reduces activation of T cells
aim is to prevent host V transplant mediated immune response

ideal treatment:
- specific
- few side effects
- able to monitor its effect on immune system

  • actual treatment is not ideal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

immunosuppressive therapy

A
  1. Induction Treatment
    Basiliximab/Dacluzimab
    Prednisolone iv during operation
  2. Maintainance Treatment
    Prednisolone, tacrolimus, MMF
    Prednisolone, ciclosporin, azathioprine
  3. Acute anti-rejection Treatments
    Pulsed iv methylprednisolone (ACR)
    Anti-thymocyte globulin (ATG), (resistant ACR and AMR))
    IV Immunoglobulin (AMR)
    Plasma exchange (AMR)
    Rituximab, Bortezimab, Eculizumab (AMR)
    & intensification of immunosupression
17
Q

infections due immunosuppresion

A

bacterial infection (common)
- UTI
- LRTI

give prophylaxis for PJP

viral infections
CMV, HSV, BK

fungal infections (rare)

18
Q

CMV

A

associated w/ early graft loss

Common if recipient not immune but donor has previous infection.

causes
renal & hepatic dysfunction
Oesophagitis, Pneumonitis & Colitis
Increased risk of rejection

evidence
IgM + & PCR +

treatment
Prophylactic PO valganciclovir in higher risk patients
IV ganciclovir if evidence of infection

19
Q

BK nephropathy

A
  • prevalent and indolent in uroepithelium
  • reflection of over immunosuppression
  • can mimic rejection
  • no effective anti-viral therapy
  • treat by reducing immunotherapy
  • monitor blood viral load by PCR
20
Q

commonest cancers in immunosupp I think

A

non-melanoma skin cancers
lymphoma (e.g. EBV mediated PTLD)
solid organs

21
Q

what is post transplant lymphoproliferative disease (ptld)

A
  • occurs in all forms of transplantation in all forms on transplantation
  • depends on level of immunosuppresion
  • usually related to EBV infection
22
Q

post transplant lymphoproliferative disease (ptld) treatment options

A

reduce immunosuppression
(easier in renal transplant than in heart)

chemotherapy

no role for antiviral therapy

23
Q

long term follow up (usuals)

A

compliance
rejection
hypertension assessment of CVS risk
chronic graft dysfunction
UTI
recurrent primary renal disease
surveillance for malignancy
viral mediated graft dysfunction
management of CKD

24
Q

causes of graft loss

A

acute rejection
death w/ a functioning graft
recurrent disease
chronic rejection
viral nephropathy
PTLD

25
relevance of induction monoclonal antibodies
basiliximab or dacluzimab block il-2 receptor on CD4 T-calle prevent activation of these cells therefore prevent rejection not useful if rejection has already started
26
how glucocorticoids are used and their side effecrs
inhibit lymphocyte proliferation, survival and activation suppress cytokines side effects: weight gain, diabetes, osteoporosis
27
e.g.gyzamples of calcineurin inhibitors and their side effects
tacrolimus & ciclosporin act by inhibiting activation of t cells prevent cytokine release side effects: renal dysfunction, hypertension, diabetes, tremor